Cormorant Asset Management LP 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:02 pm Sale |
2022-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Cormorant Asset Management LP | 4,116,949 4.670% |
-782,235 (-15.97%) |
Filing |
| 2022-02-14 3:17 pm Purchase |
2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Cormorant Asset Management LP | 4,899,184 5.600% |
4,899,184 (New Position) |
Filing |